Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
This Funding Opportunity Announcement (FOA) invites early-stage physician and other health professional investigators with a commitment to aging and/or aging-related diseases to apply for this award to advance their research and leadership skills in their specialty and in the broader field of aging and geriatrics research. The National Institute on Aging (NIA) is pursuing this initiative to recruit early-stage investigators who have begun to establish research programs and who, through this award, will be ready to assume leadership roles in their field of expertise and will be poised to change theory, practice, and health outcomes related to the health of older individuals. Unlike other mentored K awards, candidates for this award must have received competitively awarded research support as a Program Director/Principal Investigator (PD/PI) at the faculty level or have otherwise leveraged faculty-level research support to develop an independent line of research. They must show evidence of leadership in the clinical or research domain.
Funding Opportunity Number: RFA-AG-20-011
Funding Agency: NIH
Deadline: October 22, 2019
Amount: $2,000,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-011.html
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites early-stage physicians and other health professional investigators with a commitment to aging and/or aging-related diseases to apply for this award to advance their research and leadership skills in their specialty and in the broader field of aging and geriatrics research. NIA is pursuing this initiative to recruit early-stage investigators who have begun to establish research programs and who, through this award, will be ready to assume leadership roles in their field of expertise and be poised to change theory, practice, and health outcomes related to the health of older individuals. Unlike other mentored K awards, candidates for this award must have received competitively awarded research support as a PD/PI at the faculty level or have otherwise leveraged faculty-level research support to develop an independent line of research. They must show evidence of leadership in the clinical or research domain.
Funding Opportunity Number: RFA-AG-20-010
Funding Agency: NIH
Deadline: October 22, 2019
Amount: $2,000,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-010.html
Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites projects focused on defining the factors that influence microbiome composition and functional characteristics during aging, understanding how the aging microbiome relates to the causes and pathophysiology of age-related chronic diseases, and development and testing of targeted interventions through diet, drugs, or live organisms. This FOA will accept basic mechanistic, preclinical studies in animal models and human studies leveraging existing human longitudinal cohorts.
Funding Opportunity Number: RFA-AG-20-030
Funding Agency: NIH
Deadline: October 30, 2019
Amount: $2,500,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-030.html
Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R21)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that seek to identify natural products with the potential to inhibit or induce Phase I and Phase II drug metabolizing enzymes and drug transporters, thereby possibly contributing to pharmacokinetic interactions with other medications. These in vitro studies may include screening libraries of complex extracts and/or purified natural products in suitable medium to high throughput assays to identify potential interactions. They may also include isolation and identification of novel, or not commercially available, natural products within complex mixtures that exhibit pharmacokinetic interactions. This FOA is part of a larger investment from NCCIH that includes a U54 Center of Excellence for Natural Product Drug Interaction Research. It is expected that data generated in projects supported under this FOA will be uploaded and made publicly available through the data repository maintained by the U54 Center.
Funding Opportunity Number: RFA-AT-20-001
Funding Agency: NIH
Deadline: November 1, 2019
Amount: $1,500,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-20-001.html
Humanities Connections
The Humanities Connections program seeks to expand the role of the humanities in undergraduate education at two- and four-year institutions. Awards will support innovative curricular approaches that foster productive partnerships among humanities faculty and their counterparts in the social and natural sciences and in pre-service or professional programs (such as business, engineering, health sciences, law, computer science, and other technology-driven fields), in order to encourage and develop new integrative learning opportunities for students. Humanities Connections grants are funded at two levels: Planning and Implementation.
Funding Opportunity Number: 20190919-AKA
Funding Agency: NEH
Deadline: September 19, 2019
Amount: $100,000
For more information: https://www.neh.gov/divisions/education